Development of Hypocalcemia Due to Targeted Therapies
نویسندگان
چکیده
منابع مشابه
Myocardial dysfunction due to hypocalcemia.
Hypocalcemia is a curable cause of myocardial dysfunction and clinical congestive cardiac failure, with only stray reports available in literature. We describe 15 infants presenting with severe left ventricular dysfunction, who were found to have hypocalcemia with or without hypomagnesemia. Vitamin D deficiency was identified as the main cause of hypocalcemia. These children improved on supplem...
متن کاملClinical Significance of Skin Toxicity due to EGFR-Targeted Therapies
Many small molecules and monoclonal antibodies blocking the activity of Epidermal Growth factor receptor (EGFR) have been developed and have shown clinical activity in patients with non-small cell lung cancer (NSCLC), pancreatic cancer, and colorectal cancer (CRC), and are in clinical development for a range of other solid tumors. The toxicity profile of such agents is characterized by a typica...
متن کاملDevelopment of Molecularly Targeted Therapies to Treat Pediatric Malignancies
Drugs and biologics developed to treat children with cancer have been historically developed in adults for adult indications. Although leading to many useful drugs and biologics to treat pediatric cancer, future development of molecularly targeted therapies (MTTs) should be directed toward pediatric tumors more specifically to maximize antitumor efficacy while minimizing acute morbidity and lon...
متن کاملHypocalcemia due to 22q11.2 deletion syndrome diagnosed in adulthood
Chromosome 22q11.2 deletion syndrome (22q11.2DS) is a genetic syndrome that may present with hypocalcemia due to primary hypoparathyroidism (PH) at any age. We report a new diagnosis of 22q11.2DS in a 57-year-old man who presented with symptomatic hypocalcemia. It is important to consider genetic causes of hypocalcemia due to PH regardless of age. Learning points It is important to discard ge...
متن کاملNeonatal hypocalcemia due to asymptomatic maternal primary hyperparathyroidism.
Neonatal hypocalcemia resulting from maternal primary hyperparathyroidism (MPH) is usually detected clinically in the first 2 weeks of life. Occasionally, diagnosis of primary hyperparathyroidism in a young asymptomatic mother is made when the infant presents with hypocalcemia. We present an infant with late onset hypocalcemia resulting from a combination of transient hypoparathyroidism due to ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Turkish Journal of Endocrinology and Metabolism
سال: 2020
ISSN: 1301-2193,1308-9846
DOI: 10.25179/tjem.2019-70737